Materiality
73.25
Sentiment +63
Source
External coverage
Decided
2026-05-06
Novo Nordisk raised its outlook modestly, citing stronger Wegovy pill-driven sales, which is a positive near-term read-through for NVO.
NVO
Novo Nordisk A/SANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Curated Events
1
Active
Recent Headlines
0
New
Recent news sentiment
+63.0
30-day score
Company
63.0
30-day
Macro
-
30-day
Pulse
-
30-day
Curated events
Sentiment decomposition
+63.0
30-day score
Company+63.055%
Macro-30%
Pulse-15%
The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.
Top contributor
Novo Raises Forecast as Wegovy Pill Fuels Sales
+0.63 sentiment - 2026-05-06
Recent headlines
No supplemental ticker headlines stored yet
We are still collecting relevant articles for NVO. Curated events highlight the most material developments impacting this ticker right now.
As of 2026-05-06 • Updated scheduledSource: News desk